Tapewire

Nasdaq · USD

AGEN

AGENUS INC

Export transactions ↓
Tapewire entity
5774
SEC CIK
0001098972
Parsed reports
443

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2018 Filed Jan 4, 2018 21:10 UTC
WIINBERG ULFDirector
GrantDeferred Shares · Derivative 4,339.64 $3.89 Strike: $3.89 $16,876.86
Disclosure

SEC source: 0001288123-18-000002 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,339.64

Underlying: Common Stock · 4,339.64 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
January 02, 2018 Filed Jan 19, 2018 21:21 UTC Amendment GrantDeferred Shares · Derivative 1,944.802 $3.89 Strike: $3.89 $7,563.33
Disclosure

SEC source: 0001288123-18-000005 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,944.802

Underlying: Common Stock · 1,944.802 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
January 02, 2018 Filed Jan 19, 2018 21:16 UTC Amendment
JORDAN WADIHDirector
GrantDeferred Shares · Derivative 5,271.859 $3.89 Strike: $3.89 $20,502.26
Disclosure

SEC source: 0001288123-18-000004 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,271.859

Underlying: Common Stock · 5,271.859 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:38 UTC
Baysal OzerChief Commercial Officer
SaleCommon Stock 3,712 $3.46 $12,845.75
Disclosure

SEC source: 0001288123-17-000044 · primary_doc.xml · nonDerivative · entry 2

Baysal Ozer · CIK 0001579446 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,790

F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.44 per share.

F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.44 per share.

Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:33 UTC
Buell JenniferChief Communications Officer
SaleCommon Stock 3,511 $3.46 $12,151.92
Disclosure

SEC source: 0001288123-17-000043 · primary_doc.xml · nonDerivative · entry 2

Buell Jennifer · CIK 0001711184 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,656

F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and 3.43 per share.

F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and 3.43 per share.

Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:27 UTC
Duncan AlexChief Technology Officer
SaleCommon Stock 6,546 $3.46 $22,651.12
Disclosure

SEC source: 0001288123-17-000042 · primary_doc.xml · nonDerivative · entry 2

Duncan Alex · CIK 0001711183 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,026

F2 · kind: Represents sales of shares sold solely to cover Federal, State and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share.

F2 · price: Represents sales of shares sold solely to cover Federal, State and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share.

Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:21 UTC SaleCommon Stock 5,610 $3.46 $19,417.89
Disclosure

SEC source: 0001288123-17-000041 · primary_doc.xml · nonDerivative · entry 2

KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,333

F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share.

F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share.

Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:14 UTC
Valentine KarenChief Legal Officer
SaleCommon Stock 8,358 $3.46 $28,921.19
Disclosure

SEC source: 0001288123-17-000040 · primary_doc.xml · nonDerivative · entry 2

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,521

F2 · shares: Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share.

F2 · price: Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share.

Read SEC document
November 30, 2017 Filed Dec 4, 2017 21:14 UTC
ARMEN GARO HChairman and CEO
OtherCommon Stock 300,000 $3.96 $1,188,000.00
Disclosure

SEC source: 0001288123-17-000039 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,290,441

F1 · kind: Represents deposit of Agenus Inc. common shares into the Garo Armen 2017 2 Year AG GRAT.

Read SEC document
October 30, 2017 Filed Oct 30, 2017 21:05 UTC
ARMEN GARO HChairman and CEO
GrantCommon Stock 40,388 $3.61 $145,853.18
Disclosure

SEC source: 0001288123-17-000037 · primary_doc.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,590,441

Read SEC document
October 30, 2017 Filed Oct 31, 2017 14:08 UTC Amendment
ARMEN GARO HChairman & CEO
PurchaseCommon Stock 40,388 $3.61 $145,853.18
Disclosure

SEC source: 0001288123-17-000038 · primary_doc.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,590,441

Read SEC document
October 27, 2017 Filed Oct 30, 2017 21:05 UTC
ARMEN GARO HChairman and CEO
GrantCommon Stock 59,612 $3.51 $209,261.96
Disclosure

SEC source: 0001288123-17-000037 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,550,053

Read SEC document
October 27, 2017 Filed Oct 31, 2017 14:08 UTC Amendment
ARMEN GARO HChairman & CEO
PurchaseCommon Stock 59,612 $3.51 $209,261.96
Disclosure

SEC source: 0001288123-17-000038 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,550,053

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:46 UTC
ARMEN GARO HCEO and Chairman of the Board
GrantCommon Stock 71,966 $3.59 $258,357.94
Disclosure

SEC source: 0001288123-17-000045 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · CEO and Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,362,407

F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015.

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:38 UTC
Baysal OzerChief Commercial Officer
GrantCommon Stock 13,080 $3.59 $46,957.20
Disclosure

SEC source: 0001288123-17-000044 · primary_doc.xml · nonDerivative · entry 1

Baysal Ozer · CIK 0001579446 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,502

F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015.

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:33 UTC
Buell JenniferChief Communications Officer
GrantCommon Stock 10,431 $3.59 $37,447.29
Disclosure

SEC source: 0001288123-17-000043 · primary_doc.xml · nonDerivative · entry 1

Buell Jennifer · CIK 0001711184 · Chief Communications Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,167

F1 · kind: Represents settlement of restricted shares awarded on July 1, 2016.

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:27 UTC
Duncan AlexChief Technology Officer
GrantCommon Stock 13,423 $3.59 $48,188.57
Disclosure

SEC source: 0001288123-17-000042 · primary_doc.xml · nonDerivative · entry 1

Duncan Alex · CIK 0001711183 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,572

F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015.

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:21 UTC GrantCommon Stock 10,431 $3.59 $37,447.29
Disclosure

SEC source: 0001288123-17-000041 · primary_doc.xml · nonDerivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,943

F1 · shares: Represents settlement of restricted shares awarded on July 1, 2015.

Read SEC document
October 09, 2017 Filed Dec 14, 2017 21:14 UTC
Valentine KarenChief Legal Officer
GrantCommon Stock 24,824 $3.59 $89,118.16
Disclosure

SEC source: 0001288123-17-000040 · primary_doc.xml · nonDerivative · entry 1

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,879

F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:33 UTC GrantDeferred Shares · Derivative 1,742.288 $4.13 Strike: $4.13 $7,186.94
Disclosure

SEC source: 0001288123-17-000036 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,742.288

Underlying: Common Stock · 1,742.288 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:29 UTC
WIINBERG ULFDirector
GrantDeferred Shares · Derivative 4,090.589 $4.13 Strike: $4.13 $16,873.68
Disclosure

SEC source: 0001288123-17-000035 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,090.589

Underlying: Common Stock · 4,090.589 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
October 02, 2017 Filed Oct 4, 2017 21:23 UTC
JORDAN WADIHDirector
GrantDeferred Shares · Derivative 4,242.093 $4.13 Strike: $4.13 $17,498.63
Disclosure

SEC source: 0001288123-17-000034 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,242.093

Underlying: Common Stock · 4,242.093 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
September 03, 2017 Filed Sep 7, 2017 00:29 UTC
Buell JenniferVP Research & External Affairs
GrantCommon Stock 4,375 $3.72 $16,275.00
Disclosure

SEC source: 0001288123-17-000033 · primary_doc.xml · nonDerivative · entry 1

Buell Jennifer · CIK 0001711184 · VP Research & External Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,736

F1 · kind: Represents the settlement of restricted stock awarded on September 3, 2013.

Read SEC document
June 30, 2017 Filed Jul 3, 2017 15:32 UTC GrantDeferred Shares · Derivative 2,006.081 $3.58 Strike: $3.58 $7,187.79
Disclosure

SEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,006.081

Underlying: Comon Stock · 2,006.081 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
June 30, 2017 Filed Jul 3, 2017 15:23 UTC
WIINBERG ULFDirector
GrantDeferred Shares · Derivative 4,709.928 $3.58 Strike: $3.58 $16,875.67
Disclosure

SEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,709.928

Underlying: Common Stock · 4,709.928 shares

Expires not disclosed

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
June 30, 2017 Filed Jul 3, 2017 15:08 UTC
JORDAN WADIHDirector
GrantDeferred Shares · Derivative 4,186.603 $3.58 Strike: $3.58 $15,000.60
Disclosure

SEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,186.603

Underlying: Common Stock · 4,186.603 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:32 UTC GrantStock Option, Right to buy · Derivative 2,500 $3.91 Strike: $3.91 $9,775.00
Disclosure

SEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 3

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2027-06-29

F3 · derivative.exercise_date: Options vest 100% on the on-year anniversary of the grant date.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:32 UTC GrantStok Option, Right to buy · Derivative 50,000 $3.91 Strike: $3.91 $195,500.00
Disclosure

SEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 2

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date of the date of the Company's 2018 annual shareholder meeting.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:23 UTC
WIINBERG ULFDirector
GrantStock Option, Roght to buy · Derivative 50,000 $3.91 Strike: $3.91 $195,500.00
Disclosure

SEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 2

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the grant date of the award or the date of the Company's 2018 annual shareholder meeting.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:14 UTC GrantStock Option, Right to buy · Derivative 50,000 $3.91 Strike: $3.91 $195,500.00
Disclosure

SEC source: 0001288123-17-000027 · primary_doc.xml · derivative · entry 1

Sharp Shalini · CIK 0001377202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F1 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 14:57 UTC GrantStock Option, Right to buy · Derivative 2,500 $3.91 Strike: $3.91 $9,775.00
Disclosure

SEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 2

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2027-06-29

F2 · derivative.exercise_date: Option vest 100% on the one-year anniversary of the grant date.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 14:57 UTC GrantStock Option, Right to buy · Derivative 50,000 $3.91 Strike: $3.91 $195,500.00
Disclosure

SEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 1

Corvese Brian · CIK 0001393207 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F1 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:08 UTC
JORDAN WADIHDirector
GrantStock Optoin, Right to buy · Derivative 2,500 $3.91 Strike: $3.91 $9,775.00
Disclosure

SEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 3

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2027-06-29

F3 · derivative.exercise_date: Option vests 100% on the one-year anniversary of the grant date.

Read SEC document
June 29, 2017 Filed Jul 3, 2017 15:08 UTC
JORDAN WADIHDirector
GrantStock Option, Right to buy · Derivative 50,000 $3.91 Strike: $3.91 $195,500.00
Disclosure

SEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 2

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2027-06-29

F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:13 UTC
Valentine KarenChief Legal Officer
Disposition to issuerCommon Stock 8,055 $3.39 $27,306.45
Disclosure

SEC source: 0001288123-17-000022 · primary_doc.xml · nonDerivative · entry 2

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,055

F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:13 UTC
Valentine KarenChief Legal Officer
GrantCommon Stock 24,822 $3.39 $84,146.58
Disclosure

SEC source: 0001288123-17-000022 · primary_doc.xml · nonDerivative · entry 1

Valentine Karen · CIK 0001437152 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,110

F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:06 UTC
ARMEN GARO HChairman & CEO
GrantCommon Stock 71,964 $3.39 $243,957.96
Disclosure

SEC source: 0001288123-17-000021 · primary_doc.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,490,441

F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:29 UTC Disposition to issuerCommon Stock 3,733 $3.39 $12,654.87
Disclosure

SEC source: 0001288123-17-000024 · primary_doc.xml · nonDerivative · entry 2

KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,512

F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:29 UTC GrantCommon Stock 10,429 $3.39 $35,354.31
Disclosure

SEC source: 0001288123-17-000024 · primary_doc.xml · nonDerivative · entry 1

KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,245

F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:23 UTC
Baysal OzerChief Business Officer
Disposition to issuerCommon Stock 3,539 $3.39 $11,997.21
Disclosure

SEC source: 0001288123-17-000023 · primary_doc.xml · nonDerivative · entry 2

Baysal Ozer · CIK 0001579446 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,422

F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares.

Read SEC document
April 19, 2017 Filed Apr 21, 2017 20:23 UTC
Baysal OzerChief Business Officer
GrantCommon Stock 13,078 $3.39 $44,334.42
Disclosure

SEC source: 0001288123-17-000023 · primary_doc.xml · nonDerivative · entry 1

Baysal Ozer · CIK 0001579446 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,961

F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015.

Read SEC document
April 12, 2017 Filed Apr 12, 2017 21:41 UTC
ARMEN GARO HDirector · Chairman & CEO
PurchaseCommon Stock 29,456 $3.29 $97,054.57
Disclosure

SEC source: 0000899243-17-010077 · doc4.xml · nonDerivative · entry 2

ARMEN GARO H · CIK 0000935679 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,418,477

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.255 to $3.33. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares purchased at each price.

Read SEC document
April 10, 2017 Filed Apr 12, 2017 21:41 UTC
ARMEN GARO HDirector · Chairman & CEO
PurchaseCommon Stock 70,544 $3.37 $237,465.21
Disclosure

SEC source: 0000899243-17-010077 · doc4.xml · nonDerivative · entry 1

ARMEN GARO H · CIK 0000935679 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,389,021

F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.29 to $3.43. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares purchased at each price.

Read SEC document
April 03, 2017 Filed Apr 6, 2017 20:39 UTC GrantDeferred Shares · Derivative 1,586.909 $4.04 Strike: $4.04 $6,406.35
Disclosure

SEC source: 0001288123-17-000020 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,586.909

Underlying: Common Stock · 1,586.909 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
April 03, 2017 Filed Apr 6, 2017 20:29 UTC
JORDAN WADIHDirector
GrantDeferred Shares · Derivative 3,715.69 $4.04 Strike: $4.04 $15,000.24
Disclosure

SEC source: 0001288123-17-000018 · primary_doc.xml · derivative · entry 1

JORDAN WADIH · CIK 0001222090 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,715.69

Underlying: Common Stock · 3,715.69 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
April 03, 2017 Filed Apr 6, 2017 20:34 UTC
WIINBERG ULFDirector
GrantDeferred Shares · Derivative 3,406.049 $4.04 Strike: $4.04 $13,750.22
Disclosure

SEC source: 0001288123-17-000019 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,406.049

Underlying: Common Stock · 3,406.049 shares

Expires not disclosed

F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 22:49 UTC
ARMEN GARO HChairman and CEO
GrantStock Option, Right to Buy · Derivative 853,000 $3.77 Strike: $3.77 $3,215,810.00
Disclosure

SEC source: 0001288123-17-000014 · primary_doc.xml · derivative · entry 2

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 853,000

Underlying: Common Stock · 853,000 shares

Expires 2027-03-31

F2 · derivative.exercise_date: Option vests 100% on 5-year anniversary of the award provided Dr. Armen maintains a service relationship with the Company on such date.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 22:49 UTC
ARMEN GARO HChairman and CEO
GrantRestricted Stock Unit · Derivative 647,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001288123-17-000014 · primary_doc.xml · derivative · entry 1

ARMEN GARO H · CIK 0000935679 · Chairman and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647,000

Underlying: Common Stock · 647,000 shares

Expires 2022-03-31

F1 · derivative.exercise_price: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.

F1 · price: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.

F1 · derivative.exercise_date: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.

F1 · derivative.expiration_date: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 23:00 UTC
WIINBERG ULFDirector
GrantRestricted Stock Unit · Derivative 15,915 Not disclosed Not disclosed
Disclosure

SEC source: 0001288123-17-000017 · primary_doc.xml · derivative · entry 1

WIINBERG ULF · CIK 0001187314 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,915

Underlying: Common Stock · 15,915 shares

Expires 2018-03-31

F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

Read SEC document
March 31, 2017 Filed Apr 4, 2017 22:56 UTC GrantRestricted Stock Unit · Derivative 15,915 Not disclosed Not disclosed
Disclosure

SEC source: 0001288123-17-000016 · primary_doc.xml · derivative · entry 1

Wright Timothy · CIK 0001383313 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,915

Underlying: Common Stock · 15,915 shares

Expires 2018-03-31

F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.